BMY

#110
Bristol-Myers Squibb Co.
62.28
+2.40%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
62.13
62.46
Jahresspanne
42.52
63.16
Tagesänderung
+2.40%
Monatliche Änderung
+12.89%
6 month change
+30.79%
Jahresänderung
+5.56%
Vorheriger Schlusskurs
60.82
Open
62.24
Bid
Ask
Low
62.13
High
62.46
Volumen
3 679
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 126.68 B
  • Employee 33 K
  • Founded N/A
  • CEO Chris Boerner
  • Website www.bms.com
  • Headquarter Delaware, United States
  • FIGI BBG000DQLV23
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.59
Price to sales ratio
2.28
Dividends per share
2.49
Dividend yield %
4.62

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

Nachrichten